NovaBridge Biosciences appointed Chuck Silberstein as its new Chief Financial Officer, effective November 2, 2026, succeeding Kyler Lei. Silberstein brings over 25 years of experience in biotechnology leadership, corporate finance, and capital markets, previously holding CFO roles at biotech firms and working in healthcare investment. His expertise is expected to support NovaBridge's clinical development, strategic partnerships, and disciplined capital allocation as the company advances its drug portfolio. This leadership change aims to strengthen NovaBridge's financial strategy and position the company for long-term growth in the biotech sector.
NovaBridge Biosciences leadership change provides context for health sector market data. For readers following health stocks, here is Pluang's market snapshot as of Oct 28, 2026 17:41 WIB: Out of 150 priced US health stocks, 42 rose and 94 fell. GSK traded at USD 47.65 with a 1-day change of -6.46% and 100% sell order activity. GE HealthCare Technologies rose 5.99% to USD 75.37. Inovio Pharmaceuticals increased 5.21% to USD 0.94 with a near-even buy-sell split and a typical hold time of 43 days on Pluang.
Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including derma...
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
The Legacy Lab by Team One released its 2026 Legacy Makers 100 list, identifying brands consumers trust to have their best interests at heart and remain relevant long-term. St. Jude Children's Research Hospital topped the list for the second year. Th...
Circuit Mind has introduced AVE (Agentic Verification Engine), an AI-powered application that verifies printed circuit board (PCB) schematics against datasheets and internal design rules to catch errors early and avoid expensive respins. AVE compleme...
Grabar Law Office is investigating claims against officers and directors of Erasca, Planet Fitness, PROCEPT BioRobotics, and The Simply Good Foods Company for alleged breaches of fiduciary duties. The investigations focus on misleading statements and...
